SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-23-000156
Filing Date
2023-08-14
Accepted
2023-08-14 16:10:06
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1692043784.html 4  
1 FORM 4 wk-form4_1692043784.xml 4 3912
  Complete submission text file 0001824293-23-000156.txt   5435
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO CA 92121
Business Address
Szekeres David Leslie (Reporting) CIK: 0001602459 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 231170118

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations